Toxic effects of dietary exposure to T-2 toxin on intestinal and hepatic biotransformation enzymes and drug transporter systems in broiler chickens

Food and Chemical Toxicology

Volumn 55, Issue , 2013, Pages 150-155

  Osselaere, A ^a   Li, S J ^a   De Bock, L ^a   Devreese, M ^a   Goossens, J ^a   Vandenbroucke, V ^a   Van Bocxlaer, J ^a   Boussery, K ^a   Pasmans, F ^a   Martel, A ^a   De Backer, P ^a   Croubels, S ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Broiler chickens; Cytochrome P450; Drug transporter mechanisms; T 2 toxin

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A4; CYTOCHROME P450 1A5; CYTOCHROME P450 3A37; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; T 2 TOXIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOTRANSFORMATION; CHICKEN; CONTROLLED STUDY; DIETARY INTAKE; DOWN REGULATION; ENZYME ACTIVITY; ENZYME METABOLISM; EXPOSURE; FEMALE; FOOD CONTAMINATION; GASTROINTESTINAL TOXICITY; GENE EXPRESSION; LIVER MICROSOME; LIVER TOXICITY; MALE; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84873249353     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.12.055     Document Type: Article

References (51)

1. Ameer B., Weintraub R.A. Drug interactions with grapefruit juice. Clin. Pharmacokinet. 1997, 33:103-121.
2. Anonymous, 2007. Appendix A to the European Conventions for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes (ETS No. 123). Guidelines for Accomodation and Care of Animals.
3. Anonymous Scientific opinion on the risks for animal and public health related to the presence of T-2 and HT-2 toxin in food and feed. EFSA J. 2011, 9:2481.
4. Antonovic L., Martinez M. Role of the cytochrome P450 enzyme system in veterinary pharmacokinetics: where are we now? Where are we going?. Future Med. Chem. 2011, 3:855-879.
5. Beigneux A.P., Moser A.H., Shigenaga J.K., Grunfeld C., Feingold K.R. Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. Biochem. Biophys. Res. Commun. 2002, 293:145-149.
6. Bradford M.M. Rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
7. Bressler R. Grapefruit juice and drug interactions. Exploring mechanisms of this interaction and potential toxicity for certain drugs. Geriatrics 2006, 61:12-18.
8. Chen J.H., Cao J.L., Chu Y.L., Wang Z.L., Yang Z.T., Wang H.L. T-2 toxin-induced apoptosis involving Fas, p53, Bcl-xL, Bcl-2, Bax and caspase-3 signaling pathways in human chondrocytes. J. Zhejiang Univ.-Sci. B 2008, 9:455-463.
9. Cherrington N.J., Hartley D.P., Li N., Johnson D.R., Klaassen C.D. Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) rnRNA and hepatic induction of mrp3 by constitutive androstane receptor activators in rats. J. Pharm. Exp. Ther. 2002, 300:97-104.
10. Chi M.S., Robison T.S., Mirocha C.J., Swanson S.P., Shimoda W. Excretion and tissue distribution of radioactivity from tritium-labeled T-2 toxin in chicks. Toxicol. Appl. Pharm. 1978, 45:391-402.
11. Cortright K.A., Craigmill A.L. Cytochrome P450-dependent metabolism of midazolam in hepatic microsomes from chickens, turkeys, pheasant and bobwhite quail. J. Vet. Pharmacol. Ther. 2006, 29:469-476.
12. De Bock L., Boussery K., Colin P., De Smet J., T'Jollyn H., Van Bocxlaer J. Development and validation of a fast and sensitive UPLC-MS/MS method for the quantification of six probe metabolites for the in vivo determination of cytochrome P450 activity. Talanta 2012, 89:209-216.
13. Devegowda G., Murthy T.N.K. Mycotoxins: their effects in poultry and some practical solutions. The Mycotoxin Blue Book 2005, 25-56. Nottingham, United Kingdom. D.E. Diaz (Ed.).
14. Elias E., Mills C.O. Coordinated defence and the liver. Clin. Med. 2007, 7:180-184.
15. Eriksen G.S., Pettersson H. Toxicological evaluation of trichothecenes in animal feed. Anim. Feed Sci. Technol. 2004, 114:205-239.
16. Fink-Gremmels J. Mycotoxins: their implications for human and animal health. Vet. Quart. 1999, 21:115-120.
17. Galtier P., Paulin F., Eeckhoutte C., Larrieu G. Comparative effects of T-2 toxin and diacetoxyscirpenol on drug-metabolizing enzymes in rat-tissues. Food Chem. Toxicol. 1989, 27:215-220.
18. Ge X.H., Wang J.P., Liu J., Jiang J., Lin H.N., Wu J., Ouyang M., Tang X.Q., Zheng M., Liao M., Deng Y.Q. The catalytic activity of cytochrome P450 3A22 is critical for the metabolism of T-2 toxin in porcine reservoirs. Catal. Commun. 2010, 12:71-75.
19. Fukuda K., Ohta T., Oshima Y., Ohashi N., Yoshikawa M., Yamazoe Y. Specific CYP3A4 inhibitors in grapefruit juice. furocoumarin dimers as components of drug interaction. Pharmacogenetics 1997, 7:391-396.
20. Guerre P., Eeckhoutte C., Burgat V., Galtier P. The effects of T-2 toxin exposure on liver drug metabolizing enzymes in rabbit. Food Addit. Contam. 2000, 17:1019-1026.
21. Hardman J.G. Goodman & Gilman's the Pharmacological Basis of Therapeutics 2001, McGraw-Hill, New York.
22. Haritova A.M., Schrickx J., Fink-Gremmels J. Expression of drug efflux transporters in poultry tissues. Res. Vet. Sci. 2010, 89:104-107.
23. Ho P.C., Saville D.J., Wanwimolruk S. Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds. Journal of Pharmacy and Pharmaceutical Sciences: A Publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des Sciences Pharmaceutiques 2001, 4:217-227.
24. Hollenberg P.F. Mechanisms of cytochrome-P450 and peroxidase-catalyzed xenobiotic metabolism. Faseb. J. 1992, 6:686-694.
25. Honkakoski P., Negishi M. Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem. J. 2000, 347:321-337.
26. Hussein H.S., Brasel J.M. Toxicity, metabolism, and impact of mycotoxins on humans and animals. Toxicology 2001, 167:101-134.
27. Islam Z., Nagase M., Yoshizawa T., Yamauchi K.E., Sakato N. T-2 toxin induces thymic apoptosis in vivo in mice. Toxicol. Appl. Pharm. 1998, 148:205-214.
28. Kravchenko L.V., Tutelyan V.A., Vasilyev A.V., Kranauskas A.E., Avrenyeva L.I. Biochemical-changes in subacute mycotoxicosis induced by T-2-toxin in rats. Toxicology 1986, 42:77-83.
29. Kruber P., Trump S., Behrens J., Lehmann I. T-2 toxin is a cytochrome P450 1A1 inducer and leads to MAPK/p38-but not aryl hydrocarbon receptor-dependent interleukin-8 secretion in the human intestinal epithelial cell line Caco-2. Toxicology 2011, 284:34-41.
30. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods 2001, 25:402-408.
31. Lown K.S., Kolars J.C., Thummel K.E., Barnett J.L., Kunze K.L., Wrighton S.A., Watkins P.B. Interpatient heterogeneity in expression of Cyp3a4 and Cyp3a5 in small-bowel - lack of prediction by the erythromycin breath test. Drug Metab. Dispos. 1994, 22:947-955.
32. Mealey K.L. Therapeutic implications of the MDR-1 gene. J. Vet. Pharmacol. Ther. 2004, 27:257-264.
33. Meissonnier G.M., Laffitte J., Raymond I., Benoit E., Cossalter A.M., Pinton P., Bertin G., Oswald I.P., Galtier P. Subclinical doses of T-2 toxin impair acquired immune response and liver cytochrome P450 in pigs. Toxicology 2008, 247:46-54.
34. Monbaliu S., Van Poucke C., Detavernier C., Dumoulin F., Van De Velde M., Schoeters E., Van Dyck S., Averkieva O., Van Peteghem C., De Saeger S. Occurrence of mycotoxins in feed as analyzed by a multi-mycotoxin LC-MS/MS method. J. Agric. Food Chem. 2010, 58:66-71.
35. Osselaere, A., De Bock, L., eeckhaut, V., De Backer, P., Van Bocxlaer, J., Boussery, K., Croubels, S., 2013. Hepatic and intestinal CYP3A expression and activity in broilers. J. Vet. Pharmacol. Ther. http://dx.doi.org/10.1111/jvp.12034.
36. Ourlin J.C., Baader M., Fraser D., Halpert J.R., Meyer U.A. Cloning and functional expression of a first inducible avian cytochrome P450 of the CYP3A subfamily (CYP3A37). Arch. Biochem. Biophys. 2000, 373:375-384.
37. Placinta C.M., D'Mello J.P.F., Macdonald A.M.C. A review of worldwide contamination of cereal grains and animal feed with Fusarium mycotoxins. Anim. Feed Sci. Technol. 1999, 78:21-37.
38. Qiu H., Taudien S., Herlyn H., Schmitz J., Zhou Y., Chen G., Roberto R., Rocchi M., Platzer M., Wojnowski L. CYP3 phylogenomics: evidence for positive selection of CYP3A4 and CYP3A7. Pharmacogenet. Genomics 2008, 18:53-66.
39. Rocha O., Ansari K., Doohan F.M. Effects of trichothecene mycotoxins on eukaryotic cells: a review. Food Addit. Contam. 2005, 22:369-378.
40. Schmiedlin-Ren P., Thummel K.E., Fisher J.M., Paine M.F., Lown K.S., Watkins P.B. Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1 alpha,25-dihydroxyvitamin D-3. Mol. Pharmacol. 1997, 51:741-754.
41. Schollenberger M., Muller H.M., Rufle M., Suchy S., Plank S., Drochner W. Natural occurrence of 16 Fusarium toxins in grains and feedstuffs of plant origin from germany. Mycopathologia 2006, 161:43-52.
42. Sokolovic M., Garaj-Vrhovac V., Simpraga B. T-2 toxin: incidence and toxicity in poultry. Arh. Hig. Rada Toksiko 2008, 59:43-52.
43. Suneja S.K., Wagle D.S., Ram G.C. Effect of oral-administration of T-2 toxin on glutathione shuttle enzymes, microsomal reductases and lipid-peroxidation in rat-liver. Toxicon 1989, 27:995-1001.
44. Tusnady G.E., Bakos E., Varadi A., Sarkadi B. Membrane topology distinguishes a subfamily of the ATP-binding cassette (ABC) transporters. FEBS Lett. 1997, 402:1-3.
45. Usia T., Iwata H., Hiratsuka A., Watabe T., Kadota S., Tezuka Y. Sesquiterpenes and flavonol glycosides from Zingiber aromaticum and their CYP3A4 and CYP2D6 inhibitory activities. J. Nat. Prod. 2004, 67:1079-1083.
46. Verbrugghe E., Vandenbroucke V., Dhaenens M., Shearer N., Goossens J., De Saeger S., Eeckhout M., D'Herde K., Thompson A., Deforce D., Boyen F., Leyman B., Van Parys A., De Backer P., Haesebrouck F., Croubels S., Pasmans F. T-2 toxin induced salmonella typhimurium intoxication results in decreased Salmonella numbers in the cecum contents of pigs, despite marked effects on Salmonella-host cell interactions. Vet. Res. 2012, 43.
47. Wang J.S., Jiang J., Zhang H.X., Wang J.P., Cai H., Li C., Li K.B., Liu J., Guo X.J., Zou G.X., Wang D.Z., Deng Y.Q., Dai J.Y. Integrated transcriptional and proteomic analysis with in vitro biochemical assay reveal the important role of CYP3A46 in T-2 toxin hydroxylation in porcine primary hepatocytes. Mol. Cell Proteomics 2011, 10.
48. Watkins P.B. Noninvasive tests of Cyp3a enzymes. Pharmacogenetics 1994, 4:171-184.
49. Wilson Z.E., Rostami-Hodjegan A., Burn J.L., Tooley A., Boyle J., Ellis S.W., Tucker G.T. Inter-individual variability in levels of human microsomal protein and hepatocellularity per gram of liver. Brit. J. Clin. Pharmacol. 2003, 56:433-440.
50. Wu Q., Dohnal V., Huang L., Kuca K., Yuan Z. Metabolic pathways of trichothecenes. Drug Metab. Rev. 2010, 42:250-267.
51. Zhang L.L., Zhang J.R., Yu Z.G., Zhao J., Mo F., Jiang S.X. Effects of ionophores on liver CYP1A and 3A in male broilers. J. Vet. Pharmacol. Ther. 2010, 33:551-557.